Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A National Multicenter, Prospective Cohort Study on Delayed Endoscopic Direct-to-Implant Breast Reconstruction Via Transaxillary Approach Versus Latissimus Dorsi ± Implant Breast Reconstruction Following Mastectomy

NCT07757074 is registered in ClinicalTrials.gov with Du Zhenggui as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07757074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A National Multicenter, Prospective Cohort Study on Delayed Endoscopic Direct-to-Implant Breast Reconstruction Via Transaxillary Approach Versus Latissimus Dorsi ± Implant Breast Reconstruction Following Mastectomy
Lead sponsor
Du Zhenggui
Phase
Observational
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
September 30, 2028
Enrollment
268 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer